Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Takeda
University of Washington
American Regent, Inc.
Techsomed Medical Technologies LTD
Eureka Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
Università Vita-Salute San Raffaele
LEO Pharma
LEO Pharma
Georgetown University
Omega Therapeutics
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ethicon, Inc.
Fusion Pharmaceuticals Inc.
Canadian Cancer Trials Group
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Imunon
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Big Ten Cancer Research Consortium
BTG International Inc.
Cellxpert Biotechnology Corp.
Insel Gruppe AG, University Hospital Bern
Milton S. Hershey Medical Center
SC Liver Research Consortium, LLC
University of California, San Diego
New Mexico Cancer Research Alliance
University of Texas Southwestern Medical Center
Nanobiotix
Gachon University Gil Medical Center
Erasmus Medical Center
Indiana University
Assistance Publique - Hôpitaux de Paris
National Institutes of Health Clinical Center (CC)
Aeon Therapeutics (Shanghai) Co., Ltd.
Daiichi Sankyo
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Emory University